69/100
overall score
Total issues found:
323175Updated on: November 27, 2024
Data we analyse
Phishing and malware
321306
issues
Network security
53
issues
Email security
0
issues
Website security
1816
issues
Recent critical risk issues we found
84 corporate credentials stolen
21% employees reuse breached passwords
1747 SSL configuration issues found
6 critical vulnerabilities found
What information we check
Software patching
Web application security
Email security
Dark web exposure
Cybersecurity Benchmark
A comparison of this company’s cybersecurity ranking with industry averages and peer organizations
Phishing and malware
0
vs.
41
Network security
98
vs.
91
Email security
100
vs.
71
Website security
58
vs.
65
Get Your Free Report
Need help in fixing issues? Contact us and we will help you prepare an action plan to improve your risk rating.
Company overview
Bristol Myers Squibb (bms.com) is a global biopharmaceutical company that researches, develops, manufactures and commercializes innovative prescription medicines across oncology, hematology, immunology and cardiovascular disease. Science-driven and commercially focused, BMS combines large-scale manufacturing, rigorous R&D and strategic partnerships to bring therapies for serious diseases to patients worldwide.
Details
Website:
Industries:
Manufacturing
Company size:
10,001+ employees
Founded:
-
Headquarters:
3401 Princeton Pike; Lawrence Township, NJ 08648, US
Outcome reliability
We analyze billions of signals from publicly available sources to deliver validated insights into how your company is perceived externally by threat actors. These insights help security teams respond more quickly to risks, manage zero-day incidents effectively, and reduce overall exposure.
